Source Gaulton A, Kale N, van Westen GJ, Bellis LJ, Bento AP, Davies M, Hersey A, Papadatos G, Forster M, Wege P, Overington JP. A large-scale crop protection bioassay data set. Sci Data. 2015 Jul 7;2:150032. Read more ...

Structure

InChI Key SBFLXPXTIZVPFN-YMXDCFFPSA-N
Smiles CC(C)OP(=O)(OC(C)C)C(NC(=S)N[C@@H](C)C1CCCCC1)c2ccccc2
InChI
InChI=1S/C22H37N2O3PS/c1-16(2)26-28(25,27-17(3)4)21(20-14-10-7-11-15-20)24-22(29)23-18(5)19-12-8-6-9-13-19/h7,10-11,14-19,21H,6,8-9,12-13H2,1-5H3,(H2,23,24,29)/t18-,21?/m0/s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C22H37N2O3PS
Molecular Weight 440.58
AlogP 5.77
Hydrogen Bond Acceptor 4.0
Hydrogen Bond Donor 2.0
Number of Rotational Bond 11.0
Polar Surface Area 101.49
Molecular species NEUTRAL
Aromatic Rings 1.0
Heavy Atoms 29.0
Assay Description Organism Bioactivity Reference
Antiviral activity against Tobacco mosaic virus (TMV) in compound treated Nicotiana tabacum L.leaves assessed as curative effect Tobacco mosaic virus 413.4 ug.mL-1
Antiviral activity against Tobacco mosaic virus (TMV) in compound treated Nicotiana tabacum L.leaves assessed as curative effect at 250 ug/ml Tobacco mosaic virus 36.7 %
Antiviral activity against Tobacco mosaic virus (TMV) in compound treated Nicotiana tabacum L.leaves assessed as curative effect at 125 ug/ml Tobacco mosaic virus 29.0 %
Antiviral activity against Tobacco mosaic virus (TMV) in compound treated Nicotiana tabacum L.leaves assessed as curative effect at 500 ug/ml Tobacco mosaic virus 50.4 %
Antiviral activity against Tobacco mosaic virus (TMV) in compound treated Nicotiana tabacum L.leaves assessed as curative effect from local lesions at 500 ug/ml measured after 3 to 4 days Tobacco mosaic virus 50.4 %
Antiviral activity against Tobacco mosaic virus (TMV) in compound treated Nicotiana tabacum L.leaves assessed as protective effect from local lesions at 500 ug/ml measured after 3 to 4 days Tobacco mosaic virus 36.3 %

Cross References

Resources Reference
ChEMBL CHEMBL2229221
PubChem 25223759